[{"orgOrder":0,"company":"Lukas Biomedical","sponsor":"Virginia Contract Research Organization","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"TAIWAN","productType":"Cell and Gene therapy","year":"2022","type":"Inapplicable","leadProduct":"Activated T Lymphocyte","moa":"T-cell","graph1":"Oncology","graph2":"Phase II","graph3":"Lukas Biomedical","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Lukas Biomedical \/ Virginia Contract Research Organization","highestDevelopmentStatusID":"8","companyTruncated":"Lukas Biomedical \/ Virginia Contract Research Organization"}]
Find Clinical Drug Pipeline Developments & Deals by Lukas Biomedical